Last reviewed · How we verify
NCT06292312
Investigation of the Effectiveness of Craniosacral Therapy in Patients With Multiple Sclerosis.
NA trial testing Craniosacral therapy in Multiple Sclerosis in 32 participants. Currently enrolling.
15 April 2025
Quick facts
| Lead sponsor | Ankara Yildirim Beyazıt University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 32 |
| Start date | 27 February 2024 |
| Primary completion | 15 April 2025 |
| Estimated completion | 15 May 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Craniosacral therapy
- Conventional physiotherapy
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Ankara Yildirim Beyazıt University
Who can join
Adults 18 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Although the cause of Multiple Sclerosis (MS), one of the common demyelinating diseases of the central nervous system, has not yet been fully elucidated, autonomic nervous system dysfunction has been suggested in its etiology. Symptoms such as fatigue, problems with bladder, bowel, cardiovascular, sleep, sexual and sweating functions, abnormal sympathetic skin response or decreased heart rate variation support this hypothesis. In the treatment of many neurological diseases such as Multiple Sclerosis, complementary medicine practices and non-traditional therapies have recently been shown to be effective in addition to conventional practices. One of these practices, craniosacral therapy (CST), uses manual palpation and manipulation of the craniosacral system to influence sensory, motor, cognitive and emotional processes in the nervous system. In addition, it is thought that applying external force to certain bone elements can have a positive effect on various symptoms in patients with MS, based on the knowledge that it can be transmitted within the system.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06292312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Craniosacral therapy
Trials testing the same drug.
- NCT04319510 — Supportive Effects of Craniosacral Therapy for Women With Breast Cancer · NA · completed
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Ankara Yildirim Beyazıt University trials
Trials by the same sponsor.
- NCT07530835 — Occlusal Changes After Modified Hall Technique in Molars Affected by Molar-Incisor Hypomineralization · NA · not yet recruiting
- NCT07496853 — Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke · NA · recruiting
- NCT07441668 — Comfort Intervention in PICU Children · NA · not yet recruiting
- NCT07431151 — Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Suba · NA · recruiting
- NCT07247903 — The Impact of Patient Education Delivered Through Virtual Reality · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06292312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Yildirim Beyazıt University
- Last refreshed: 30 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06292312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing